Skip to content

Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia

Ruzmayuddin Mamat, Rusdi Abd Rashid, Baharudin Ibrahim, Suzaily Wahab, Azmir Ahmad, Maw Shin Sim

Journal of Addictive Diseases August 4, 2023 DOI: 10.1080/10550887.2023.2240932 via OpenAlex

Summary

AI-generated from the abstract

Psilocybin use in vaping is increasing among amphetamine-type stimulant users and across broader populations, yet knowledge about its long-term health effects remains limited. The authors call for further research to highlight harmful effects and the potential risks of psilocybin vaping, especially among younger people.

Study at a glance

Characteristics Review Peer reviewed
Topics Cannabis Psilocybin
Keywords Medicine Hallucinogen Psychiatry
Citations 2
Key finding Psilocybin vaping is growing among ATS users and across populations, but long-term health effects are poorly understood.

Abstract

Psilocybin in vaping is growing among ATS users and across all populations. Unfortunately, knowledge regarding the long-term effects on health is limited. Further studies should highlight the harmful effects of psilocybin and the potential risk of psilocybin vaping among the younger population.

Explore topics

Comments

No comments yet.

Log in to comment